Codexis Company Insiders
| CDXS Stock | USD 1.61 0.34 26.77% |
Codexis' insiders are aggressively selling. The analysis of insiders' sentiment of trading Codexis stock suggests that virtually all insiders are panicking at this time. Codexis employs about 188 people. The company is managed by 19 executives with a total tenure of roughly 14 years, averaging almost 0.0 years of service per executive, having 9.89 employees per reported executive.
| John Nicols CEO CEO and President and Director |
Insider Sentiment
Mostly Selling
Selling | Buying |
Latest Trades
| 2026-02-24 | Stefan Lutz | Disposed 5862 @ 1.13 | View | ||
| 2026-02-06 | Stefan Lutz | Disposed 2492 @ 1.31 | View | ||
| 2026-01-07 | Stefan Lutz | Disposed 4685 @ 1.7 | View | ||
| 2025-10-13 | Georgia Erbez | Disposed 6239 @ 2.5 | View |
Following insider trading sentiment in Codexis can help investors add context around confidence, timing, and operating risk while the public narrative is still evolving. The signal is still regulated and disclosed under securities law, which is why the public filing record matters more than rumor or interpretation alone.
Codexis has a market cap of 154.45 M, operating margin of 35.89%, ROE of -74.88%. Use Trending Equities to explore allocation context. This includes a position in Codexis within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median.Codexis Management Team Effectiveness
The company has return on total asset (ROA) of -16.14 % meaning that the return on assets was negative, reflecting a $16.14 loss per $100. This sits far below comparable companies. Similarly, it shows a return on stockholder's equity (ROE) of -74.88 %, suggesting that it is drawing down equity without generating offsetting profit.As of now, Common Stock Shares Outstanding is anticipated to decline to approximately 46 M. In addition to that, Net Loss is anticipated to decline to approximately -40.6 M
Stock Ownership Analysis
About 73.0% of the company shares are held by institutions such as insurance companies. The book value of Codexis was currently reported as 0.56. The company recorded a loss per share of 0.73. Codexis had not issued any dividends in recent years.Reviewing share-based compensation in Codexis helps investors understand how management balances employee incentives against dilution risk. Shares outstanding are near 90.3 M. That is why investors should compare compensation intensity with revenue growth, margin progress, and free-cash-flow generation.
Codexis Quarterly Liabilities And Stockholders Equity | 147.8 Million |
Reviewing insider ownership in Codexis helps investors understand how much of the equity base is controlled by people involved in running the business. Insiders currently hold about 2.60% of outstanding shares. Investors usually want to know whether that level supports alignment without creating excessive control risk. View all of Codexis' insider trades
Stock Institutional Investors
Institutional ownership matters in Codexis because pension funds, mutual funds, banks, and advisers can materially influence liquidity, governance, and price discovery. Used correctly, institutional data helps investors understand who may be setting the marginal price and how resilient that holder base could be under stress.
| Shares | Franklin Resources Inc | 2025-09-30 | 756.2 K | Renaissance Technologies Corp | 2025-12-31 | 737.5 K | The Goldman Sachs Group Inc | 2025-09-30 | 724.3 K | Northern Trust Corp | 2025-09-30 | 645.3 K | Fmr Inc | 2025-12-31 | 641.9 K | Prescott Group Capital Management Llc | 2025-09-30 | 635.5 K | D. E. Shaw & Co Lp | 2025-12-31 | 628.3 K | Assenagon Asset Management Sa | 2025-12-31 | 566.5 K | Private Advisor Group, Llc | 2025-09-30 | 561.4 K | Aberdeen Group Plc | 2025-12-31 | 8 M | Blackrock Inc | 2025-09-30 | 7.1 M |
Insider Trading Activities
Insider trading disclosures for Codexis offer a structured way to watch how people closest to the business are behaving while expectations change across the market. Current market capitalization is about 154.45 Million. Used properly, these records are better for context than for blind buy-or-sell signals.
Outstanding Bonds
Reviewing Codexis bond obligations helps investors understand how much of the business is financed with fixed-income capital rather than purely with equity. This is why bond analysis is not just a credit exercise; it also informs equity holders about solvency, optionality, and future capital-allocation pressure.
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Shares in Circulation | First Issued 2007-03-31 | Previous Quarter 90.3 M | Current Value 90.9 M | Average Shares Outstanding 47 M | Quarterly Volatility 21.9 M |
Macro event markers
Codexis Stock Holders Distribution
Institutional ownership analysis for Codexis matters because banks, hedge funds, pension plans, and other professional investors can influence price and liquidity more forcefully than smaller holders. This matters because getting in early on a sponsorship cycle may help, but getting caught near a large-holder exit can have the opposite effect.
Codexis Market Cap and Value
Codexis Workforce Comparison
Codexis maintains a second standing in number of employees relative to competitors. The total workforce of Health Care industry is currently estimated at about 1,288. Codexis retains roughly 188 in number of employees claiming about 15% of equities under Health Care sector.
Codexis Profit Margins
The company has Profit Margin (PM) of -62.0 %, which suggests pricing discipline or cost control requires further improvement. This sits far below comparable companies. Similarly, it shows Operating Margin (OM) of 36.0 %, which implies that the business converts $36.0 of every $100 in sales to operating income.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.6 | 0.8673 |
|
|
Codexis Insider Trading History
Insider trading disclosures for Codexis offer a structured way to watch how people closest to the business are behaving while expectations change across the market. Current market capitalization is about 154.45 Million. Used properly, these records are better for context than for blind buy-or-sell signals.
Codexis Notable Stakeholders
Stakeholders matter for Codexis because not every influential participant is a shareholder acting with the same objective or time horizon. This becomes more informative when investors want to understand not just ownership, but influence, incentives, and strategic pressure points.
| Stephen MBBS | CEO President | Profile | |
| John Nicols | CEO and President and Director | Profile | |
| Carrie McKim | Director Relations | Profile | |
| Sriram MBA | Chief Officer | Profile | |
| Georgia Erbez | Chief Officer | Profile | |
| MBA Taylor | VP CFO | Profile | |
| Asli Aras | VP Devel | Profile | |
| Britton Jiminez | Senior Marketing | Profile | |
| Britton Jimenez | Senior Marketing | Profile | |
| Margaret JD | General Officer | Profile | |
| John Schiffhauer | Senior Property | Profile | |
| Rob Wilson | VP Enzymes | Profile | |
| Senator MBA | Consultant | Profile | |
| MS MBA | Chief Officer | Profile | |
| Karen FrechouArmijo | Senior Resources | Profile | |
| Karl Schoene | Sr Operations | Profile | |
| Robert MBA | Quality Development | Profile | |
| Alison Moore | Chief Officer | Profile | |
| Stefan Lutz | Senior Research | Profile |
Management Information & Data Sources
Codexis is a micro-cap company in Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care. Executive review focuses on insiders, senior management, and employee signals. Insider activity can provide context on alignment between management and outside holders. CEO is Stephen MBBS with 188 employees and 19 reported executives.
Unless otherwise specified, data for Codexis is compiled from periodic company reporting and market reference feeds and standardized for comparability. Updates may occur throughout the day. Insider and management fields are mapped from published filings and company disclosures.
This content is curated and reviewed by:
Ellen Johnson - Member of Macroaxis Editorial BoardWorkforce Efficiency and Productivity
Investors reviewing Codexis can use workforce efficiency as another lens on execution, especially when comparing similar businesses in the same industry. A disciplined workforce review can reveal whether execution quality is improving beneath the top-line numbers.
Codexis Manpower Efficiency
Return on Codexis Manpower
| Revenue Per Employee | 374.4K | |
| Revenue Per Executive | 3.7M | |
| Net Loss Per Employee | 233.9K | |
| Net Loss Per Executive | 2.3M | |
| Working Capital Per Employee | 399.6K | |
| Working Capital Per Executive | 4M |
Additional Tools for Codexis Stock Analysis
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Holdings Check your current holdings and cash position to determine if your portfolio needs rebalancing |